Patents Assigned to NURO CORP.
  • Patent number: 11484243
    Abstract: A device is provided for diagnostic measurement by simultaneous multimodal analysis of a subject's head wherein the cerebral blood flow variations as well as the concentration level of oxygenation in the subject's blood are used to determine the presence and the pathophysiology of neurocognitive disorders, including the neurodegenerative disease referred to as Alzheimer's disease.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: November 1, 2022
    Assignee: NURO CORP.
    Inventor: Francois Gand